Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Armolipid Prev
- Development stage
- Unknown
- Lead developer
- Rotta Research
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Armolipid Prev is a multi-ingredient nutraceutical combination designed to manage cardiovascular risk by targeting both lipid levels and blood pressure. It contains a patented blend of orthosiphon (for antihypertensive and antidyslipidaemic effects), berberine (for lipid management), red yeast rice (containing monacolin K for cholesterol reduction), policosanol, coenzyme Q10 (CoQ10), and folic acid (to reduce homocysteine levels). Developed and studied by researchers at the Federico II University, it is intended for patients with mild-to-moderate dyslipidemia and elevated blood pressure who do not yet meet the criteria for pharmacological intervention according to current guidelines.
- Brand names
- Armolipid Prev
02
Targets
HMGCR (3-hydroxy-3-methylglutaryl-coenzyme A reductase)AMPK (Adenosine monophosphate–activated protein kinase)
Beyond the preview
Go deeper on Armolipid Prev.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Armolipid Prev.